Home The Word Brain	My Amedeo FAQ Privacy About
	C49 In our changing world, speaking just English isn't enough. Open new doors with skills in another world language. Start with 7 words a day. Next week: +49.

Breast Cancer

Free Subscription Articles published in Nat Rev Clin Oncol Retrieve available abstracts of 11 articles: HTML format

Single Articles

January 2025
1. SIDAWAY P
   Women with clinically node negative breast cancer can safely avoid axillary surgery.
   Nat Rev Clin Oncol. 2025 Jan 3. doi: 10.1038/s41571-024-00982.
   PubMed    
   
   
   November 2024
2. KILLOCK D
   First-line triplet therapy for advanced-stage PIK3CA-mutant HR(+) breast cancer improves outcomes.
   Nat Rev Clin Oncol. 2024 Nov 12. doi: 10.1038/s41571-024-00968.
   PubMed    
   
   
   
3. DRAGO J, Modi S
   Expanding the use of T-DXd in metastatic HR-positive breast cancer: where are we now?
   Nat Rev Clin Oncol. 2024 Nov 6. doi: 10.1038/s41571-024-00963.
   PubMed    
   
   
   
4. WAKS AG, Martinez-Saez O, Tarantino P, Braso-Maristany F, et al
   Dual HER2 inhibition: mechanisms of synergy, patient selection, and resistance.
   Nat Rev Clin Oncol. 2024;21:818-832.
   PubMed     Abstract available
   
   
   August 2024
5. LLOYD MR, Jhaveri K, Kalinsky K, Bardia A, et al
   Precision therapeutics and emerging strategies for HR-positive metastatic breast cancer.
   Nat Rev Clin Oncol. 2024 Aug 23. doi: 10.1038/s41571-024-00935.
   PubMed     Abstract available
   
   
   
6. MARRA A, Chandarlapaty S, Modi S
   Author Correction: Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives.
   Nat Rev Clin Oncol. 2024 Aug 2. doi: 10.1038/s41571-024-00933.
   PubMed    
   
   
   July 2024
7. YOON J, Oh DY
   HER2-targeted therapies beyond breast cancer - an update.
   Nat Rev Clin Oncol. 2024 Jul 22. doi: 10.1038/s41571-024-00924.
   PubMed     Abstract available
   
   
   June 2024
8. KILLOCK D
   ALND can be safely omitted for patients with sentinel-node macrometastases.
   Nat Rev Clin Oncol. 2024;21:402.
   PubMed    
   
   
   May 2024
9. DIECI MV, Guarneri V
   Gaining ground in personalized breast cancer therapy: lesson learned from PHERGain.
   Nat Rev Clin Oncol. 2024 May 22. doi: 10.1038/s41571-024-00907.
   PubMed    
   
   
   April 2024
10. SIDAWAY P
    KN046 shows tolerability and activity in TNBC.
    Nat Rev Clin Oncol. 2024;21:251.
    PubMed    
    
    
    March 2024
11. KONTOS D
    The promise of AI in personalized breast cancer screening: are we there yet?
    Nat Rev Clin Oncol. 2024 Mar 12. doi: 10.1038/s41571-024-00877.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.